Activation of JNK Pathway in Persistent Pain

Overview

Journal Neurosci Lett

Specialty Neurology

Date 2008 May 6

PMID 18455869

Citations 62

Authors

Yong-Jing Gao

Ru-Rong Ji

Affiliations

Soon will be listed here.

Abstract

The c-Jun N-terminal kinase (JNK) is a stress-activated member of MAP kinase family. JNK activation has been strongly implicated in inflammatory responses, neurodegeneration, and apoptosis. Recent evidence shows that JNK pathway is also transiently activated in primary sensory neurons after tissue or nerve injury, which is required for the development of hyperalgesia and allodynia. In particular, JNK is persistently activated in astrocytes of the spinal cord after nerve injury, and this activation can maintain central sensitization and mechanical allodynia. In this mini-review, we will provide evidence for the involvement of JNK pathway in regulating persistent pain sensitization. We will also discuss possible upstream signaling mechanisms that cause JNK activation and downstream signaling mechanisms by which JNK modulates pain sensitivity. Thus, targeting JNK pathway might be a useful strategy to treat both neurodegeneration and chronic pain.

Citing Articles

Neuroinflammatory Pathways Associated with Chronic Post-Thoracotomy Pain: A Review of Current Literature.

Sherbini A, Hasheminia A, Gemae M, Ansari F, Anood A, Saha T Mol Neurobiol. 2024; 62(4):4641-4653.

PMID: 39467985 DOI: 10.1007/s12035-024-04565-y.

Battling pain from osteoarthritis: causing novel cell death.

Zhang Y, Tao H, Zhang L, Li X, Shi Y, Sun W Acta Biochim Biophys Sin (Shanghai). 2024; 57(2):169-181.

PMID: 39463202 PMC: 11877141. DOI: 10.3724/abbs.2024189.

Apocynin Prevents Cigarette Smoke-Induced Anxiety-Like Behavior and Preserves Microglial Profiles in Male Mice.

Alateeq R, Akhtar A, De Luca S, Chan S, Vlahos R Antioxidants (Basel). 2024; 13(7).

PMID: 39061923 PMC: 11274253. DOI: 10.3390/antiox13070855.

Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies.

Armstrong M, Castellanos J, Christie D Front Pain Res (Lausanne). 2024; 5:1346053.

PMID: 38706873 PMC: 11066302. DOI: 10.3389/fpain.2024.1346053.

Modification of Mesenchymal Stem/Stromal Cell-Derived Small Extracellular Vesicles by Calcitonin Gene Related Peptide (CGRP) Antagonist: Potential Implications for Inflammation and Pain Reversal.

Liebmann K, Castillo M, Jergova S, Best T, Sagen J, Kouroupis D Cells. 2024; 13(6.

PMID: 38534328 PMC: 10969778. DOI: 10.3390/cells13060484.

References

Jin S, Zhuang Z, Woolf C, Ji R . p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci. 2003; 23(10):4017-22. PMC: 6741086. View

Kehlet H, Jensen T, Woolf C . Persistent postsurgical pain: risk factors and prevention. Lancet. 2006; 367(9522):1618-25. DOI: 10.1016/S0140-6736(06)68700-X. View

Kawasaki T, Kitao T, Nakagawa K, Fujisaki H, Takegawa Y, Koda K . Nitric oxide-induced apoptosis in cultured rat astrocytes: protection by edaravone, a radical scavenger. Glia. 2007; 55(13):1325-33. DOI: 10.1002/glia.20541. View

Ji R, Kohno T, Moore K, Woolf C . Central sensitization and LTP: do pain and memory share similar mechanisms?. Trends Neurosci. 2003; 26(12):696-705. DOI: 10.1016/j.tins.2003.09.017. View

Motta E, Calixto J, Rae G . Mechanical hyperalgesia induced by endothelin-1 in rats is mediated via phospholipase C, protein kinase C, and MAP kinases. Exp Biol Med (Maywood). 2006; 231(6):1141-5. View

Katsura H, Obata K, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H . Activation of extracellular signal-regulated protein kinases 5 in primary afferent neurons contributes to heat and cold hyperalgesia after inflammation. J Neurochem. 2007; 102(5):1614-1624. DOI: 10.1111/j.1471-4159.2007.04698.x. View

Keramaris E, Vanderluit J, Bahadori M, Mousavi K, Davis R, Flavell R . c-Jun N-terminal kinase 3 deficiency protects neurons from axotomy-induced death in vivo through mechanisms independent of c-Jun phosphorylation. J Biol Chem. 2004; 280(2):1132-41. DOI: 10.1074/jbc.M410127200. View

Sommer C, Kress M . Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004; 361(1-3):184-7. DOI: 10.1016/j.neulet.2003.12.007. View

Ma W, Quirion R . Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus. Pain. 2002; 99(1-2):175-84. DOI: 10.1016/s0304-3959(02)00097-0. View

10.

Weston C, Davis R . The JNK signal transduction pathway. Curr Opin Cell Biol. 2007; 19(2):142-9. DOI: 10.1016/j.ceb.2007.02.001. View

11.

Winkelstein B, Rutkowski M, Sweitzer S, Pahl J, DeLeo J . Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J Comp Neurol. 2001; 439(2):127-39. View

12.

Liu Y, Zhou L, Hu N, Xu J, Wu C, Zhang T . Tumor necrosis factor-alpha induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, JNK and p38 MAPK. Neuropharmacology. 2006; 52(3):708-15. DOI: 10.1016/j.neuropharm.2006.09.011. View

13.

Walsh G, Orike N, Kaplan D, Miller F . The invulnerability of adult neurons: a critical role for p73. J Neurosci. 2004; 24(43):9638-47. PMC: 6730156. DOI: 10.1523/JNEUROSCI.1299-04.2004. View

14.

Zhuang Z, Wen Y, Zhang D, Borsello T, Bonny C, Strichartz G . A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci. 2006; 26(13):3551-60. PMC: 6673862. DOI: 10.1523/JNEUROSCI.5290-05.2006. View

15.

Dworkin R, Backonja M, Rowbotham M, Allen R, Argoff C, Bennett G . Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003; 60(11):1524-34. DOI: 10.1001/archneur.60.11.1524. View

16.

Madiai F, Goettl V, Hussain S, Clairmont A, Stephens Jr R, Hackshaw K . Anti-fibroblast growth factor-2 antibodies attenuate mechanical allodynia in a rat model of neuropathic pain. J Mol Neurosci. 2005; 27(3):315-24. DOI: 10.1385/JMN:27:3:315. View

17.

Schafers M, Sommer C . Anticytokine therapy in neuropathic pain management. Expert Rev Neurother. 2007; 7(11):1613-27. DOI: 10.1586/14737175.7.11.1613. View

18.

Johnson G, Lapadat R . Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002; 298(5600):1911-2. DOI: 10.1126/science.1072682. View

19.

Falsig J, Porzgen P, Lotharius J, Leist M . Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347. J Immunol. 2004; 173(4):2762-70. DOI: 10.4049/jimmunol.173.4.2762. View

20.

Bogoyevitch M, Kobe B . Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev. 2006; 70(4):1061-95. PMC: 1698509. DOI: 10.1128/MMBR.00025-06. View